GGrantIndex
Sort

46,585 grants matching heart failure

Heart and Skeletal Muscle Metabolism, Energetics and Function in Barth Syndrome

$489,168
William Todd Cade · Washington University · R01 · FY2014 · HL

Multipotent stem cells for tissue regeneration

$489,164
Song Li · University Of California Berkeley · R01 · FY2012 · EB

Control of Meiosis and Germline Proliferation

$489,058
David I Greenstein · University Of Minnesota · R01 · FY2016 · GM

Control of Meiosis and Germline Proliferation

$489,058
David I Greenstein · University Of Minnesota · R01 · FY2015 · GM

Control of Meiosis and Germline Proliferation

$489,058
David I Greenstein · University Of Minnesota · R01 · FY2017 · GM

MAE-WEST SCORE Project 2 Clinical

$489,013
C. Noel Bairey Merz · Cedars-Sinai Medical Center · U54 · FY2020 · AG

Smad2 in vascular smooth muscle homeostasis

$488,997
Shiyou Chen · University Of Georgia · R01 · FY2017 · HL

Smad2 in vascular smooth muscle homeostasis

$488,997
Shiyou Chen · University Of Georgia · R01 · FY2018 · HL

Smad2 in vascular smooth muscle homeostasis

$488,997
Shiyou Chen · University Of Georgia · R01 · FY2019 · HL

Regulation of Cardiac Calcium Transport

$488,949
Seth L Robia · Loyola University Chicago · R01 · FY2021 · HL

Molecular Imaging of Cardiac Pluripotent Stem Cells

$488,922
Joseph C Wu · Stanford University · R01 · FY2016 · HL

Cardiovasology

$488,908
Andre Terzic · Mayo Clinic Rochester · T32 · FY2022 · HL

Lysosome dysfunction in podocytopathy and associated hypertension

$488,899
Pin-Lan Li · Virginia Commonwealth University · R01 · FY2019 · DK

Lysosome dysfunction in podocytopathy and associated hypertension

$488,899
Pin-Lan Li · Virginia Commonwealth University · R01 · FY2022 · DK

Lysosome dysfunction in podocytopathy and associated hypertension

$488,899
Pin-Lan Li · Virginia Commonwealth University · R01 · FY2020 · DK

Lysosome dysfunction in podocytopathy and associated hypertension

$488,899
Pin-Lan Li · Virginia Commonwealth University · R01 · FY2021 · DK

SKNA as a biomarker for cardiovascular events

$488,884
Thomas H Everett · Indiana University Indianapolis · R01 · FY2024 · HL

hiPSC-Cardiomyocytes to Screen Variants Predictive of Doxorubicin Cardiotoxicity

$488,873
Daniel Bernstein · Stanford University · R33 · FY2016 · HL

MicroRNA as mediators of angiogenesis & ischemic myocardial repair

$488,868
Meifeng Xu · University Of Cincinnati · R01 · FY2014 · HL

Overcoming Barries to Mixed-chimerism Induced Tolerance

$488,731
James S. Allan · Massachusetts General Hospital · P01 · FY2009 · HL

Multipotent stem cells for tissue regeneration

$488,725
Song Li · University Of California Berkeley · R01 · FY2011 · EB

Role of Redox-Mediated Activation of NFkappaB and AP-1 in Neurogenic Hypertension

$488,688
Robin L. Davisson · Cornell University · R01 · FY2010 · HL

Pathophysiology of Osteoporosis

$488,664
Sundeep Khosla · Mayo Clinic Rochester · P01 · FY2015 · AG

CT-Based Diagnosis of Diffuse Coronary Artery Disease

$488,644
Ghassan S Kassab · Indiana University Indianapolis · R01 · FY2009 · HL

A Novel Driver of Hyperphosphatemia and Vascular Calcification in CKD

$488,632
Makoto Miyazaki · University Of Colorado Denver · R01 · FY2023 · DK